Home|Best-Bschool-in-india-2018

DSIJ Mindshare

In conversation with Sanjeev Aggarwal, CFO, JK Tyre and Industries Ltd In conversation with Sanjeev Aggarwal, CFO, JK Tyre and Industries Ltd

In conversation with Sanjeev Aggarwal, CFO, JK Tyre and Industries Ltd

We are dedicated to driving premiumisation by expanding our TBR, PCR, and EV tyre portfolio, focusing on high-performance, fuel-efficient products and advanced tyre technologies, voices Sanjeev Aggarwal, CFO, JK Tyre & Industries Ltd.

DSIJ Intelligence 0 243 Article rating: 5.0

We are dedicated to driving premiumisation by expanding our TBR, PCR, and EV tyre portfolio, focusing on high-performance, fuel-efficient products and advanced tyre technologies, voices Sanjeev Aggarwal, CFO, JK Tyre & Industries Ltd.

Read more
Interview with Prithish Chowdhary, Dy. Managing Director, Titagarh Rail Systems Limited Interview with Prithish Chowdhary, Dy. Managing Director, Titagarh Rail Systems Limited

Interview with Prithish Chowdhary, Dy. Managing Director, Titagarh Rail Systems Limited

With our diversified product portfolio, robust manufacturing expertise, and strategic growth initiatives, we are poised to seize emerging opportunities, driving sustained growth and long-term value for our stakeholders, expresses Prithish Chowdhary, Dy. Managing Director, Titagarh Rail Systems Limited.

DSIJ Intelligence 0 491 Article rating: 3.8

With our diversified product portfolio, robust manufacturing expertise, and strategic growth initiatives, we are poised to seize emerging opportunities, driving sustained growth and long-term value for our stakeholders, expresses Prithish Chowdhary, Dy. Managing Director, Titagarh Rail Systems Limited.

Read more
India’s leading plastics product manufacturer to Acquire Wavin India’s Piping Business for USD 30 Million, Expanding Capacity by 73,000 MT and Gaining Exclusive Technology Access for Seven Years India’s leading plastics product manufacturer to Acquire Wavin India’s Piping Business for USD 30 Million, Expanding Capacity by 73,000 MT and Gaining Exclusive Technology Access for Seven Years

India’s leading plastics product manufacturer to Acquire Wavin India’s Piping Business for USD 30 Million, Expanding Capacity by 73,000 MT and Gaining Exclusive Technology Access for Seven Years

With a PE ratio of 41.4x, the company trades at a premium compared to the industry PE of 27.4x. The company has ROCE of 28.6 per cent and ROE of 21.7 per cent.

DSIJ Intelligence 0 242 Article rating: 5.0
Read more
In conversation with Naveen Philip, Promoter and MD of Popular Vehicles And Services Ltd In conversation with Naveen Philip, Promoter and MD of Popular Vehicles And Services Ltd

In conversation with Naveen Philip, Promoter and MD of Popular Vehicles And Services Ltd

With a diversified product portfolio across passenger, commercial, and electric vehicles and an expansive network, the company is well-positioned to cater to the anticipated rise in demand across urban, semi-urban, and rural markets, states Naveen Philip, Promoter and MD of Popular Vehicles And Services Ltd.

DSIJ Intelligence 0 304 Article rating: 4.9

With a diversified product portfolio across passenger, commercial, and electric vehicles and an expansive network, the company is well-positioned to cater to the anticipated rise in demand across urban, semi-urban, and rural markets, states Naveen Philip, Promoter and MD of Popular Vehicles And Services Ltd.

Read more
In conversation with Krishna Raghunathan, CFO of Supriya Lifescience Ltd In conversation with Krishna Raghunathan, CFO of Supriya Lifescience Ltd

In conversation with Krishna Raghunathan, CFO of Supriya Lifescience Ltd

Today's customers are more informed, and regulatory expectations for quality are higher than ever. Given these factors, I believe the Indian pharmaceutical industry is set for continued growth and global leadership, states Krishna Raghunathan, CFO of Supriya Lifescience Ltd.

DSIJ Intelligence 0 240 Article rating: 4.2

Today's customers are more informed, and regulatory expectations for quality are higher than ever. Given these factors, I believe the Indian pharmaceutical industry is set for continued growth and global leadership, states Krishna Raghunathan, CFO of Supriya Lifescience Ltd.

Read more
RSS
1345678910Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList